IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i2p949-d725414.html
   My bibliography  Save this article

Trends in Pancreatic Cancer Incidence and Mortality in Lithuania, 1998–2015

Author

Listed:
  • Povilas Kavaliauskas

    (Laboratory of Cancer Epidemiology, National Cancer Institute, LT-08406 Vilnius, Lithuania)

  • Audrius Dulskas

    (Laboratory of Clinical Oncology, National Cancer Institute, 1 Santariskiu Str., LT-08406 Vilnius, Lithuania
    Clinic of Internal Medicine, Family Medicine and Oncology Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, M. K. Čiurlionio Str. 21/27, LT-03101 Vilnius, Lithuania)

  • Inga Kildusiene

    (Laboratory of Cancer Epidemiology, National Cancer Institute, LT-08406 Vilnius, Lithuania)

  • Rokas Arlauskas

    (Department of Public Health, Institute of Health Sciences, Faculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania)

  • Rimantas Stukas

    (Department of Public Health, Institute of Health Sciences, Faculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania)

  • Giedre Smailyte

    (Laboratory of Cancer Epidemiology, National Cancer Institute, LT-08406 Vilnius, Lithuania
    Department of Public Health, Institute of Health Sciences, Faculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania)

Abstract

Background: Pancreatic cancer is one of the deadliest cancers worldwide, and its incidence is increasing. The aim of this study was to examine the time trends in the incidence and mortality rates of pancreatic cancer for the period of 1998–2015 for the first time in Lithuania by sex, age, subsite, and stage. Methods: This study was based on all cases (deaths) of pancreatic cancer diagnosed between 1998 and 2015. Age-standardized incidence (mortality) rates and group-specific rates were calculated for each sex using the direct method (European Standard). TNM classification-based information reported to the cancer registry was grouped into three categories: (1) localized cancer: T1-3/N0/M0; (2) cancer with regional metastasis: any 1-3/N+/M0; (3) advanced cancer: any T/any N/M+. Joinpoint regression was used to provide annual percentage changes (APCs) and to detect points in time where statistically significant changes in the trends occurred. Results: Overall, 8514 pancreatic cancer cases (4364 in men and 3150 in women) were diagnosed and 7684 persons died from cancer of the pancreas. Pancreatic cancer incidence rates were considerably lower for women than for men, with a female:male ratio of 1:2. Incidence rates changed during the study period from 14.2 in 1998 to 15.0/100,000 in the year 2015 in men, and from 6.7 to 9.8/100,000 in women. Incidence rates over the study period were stable for men (APC = 0.1%) and increasing for women by 1.1% per year. Similarly, mortality rates increased in women by 0.9% per year, and were stable in men. During the study period, incidence and mortality rates of pancreatic cancer were close. For the entire study period, rates increased significantly in the 50–74 years age group; only cancer of the head of pancreas showed a decline by 0.9%, while tail and not-specified pancreatic cancer incidence increased by 11.4% and 4.51%, respectively. Conclusions: The increasing pancreatic cancer incidence trend in the Lithuanian population may be related to the prevalence of its main risk factors (smoking, obesity, physical inactivity, diet, and diabetes).

Suggested Citation

  • Povilas Kavaliauskas & Audrius Dulskas & Inga Kildusiene & Rokas Arlauskas & Rimantas Stukas & Giedre Smailyte, 2022. "Trends in Pancreatic Cancer Incidence and Mortality in Lithuania, 1998–2015," IJERPH, MDPI, vol. 19(2), pages 1-8, January.
    • Handle: RePEc:gam:jijerp:v:19:y:2022:i:2:p:949-:d:725414
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/2/949/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/19/2/949/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Audrius Dulskas & Ausvydas Patasius & Donata Linkeviciute-Ulinskiene & Lina Zabuliene & Giedre Smailyte, 2020. "Cohort Study of Antihyperglycemic Medication and Pancreatic Cancer Patients Survival," IJERPH, MDPI, vol. 17(17), pages 1-11, August.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.

      Corrections

      All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:2:p:949-:d:725414. See general information about how to correct material in RePEc.

      If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

      If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

      If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

      For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

      Please note that corrections may take a couple of weeks to filter through the various RePEc services.

      IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.